Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTICAL: Perioperative vs Postoperative Chemotherapy in Locally Advanced Colon Cancer
NCT02572141Phase 3Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2015
- Primary completion
- Mar 2023
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin, fluorouracil, capecitabine and folinic acid in colon cancer (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Disease-Free Survival at 3 years. Started Jan 2015; status: active, not recruiting.
02
Drugs
oxaliplatinfluorouracilcapecitabinefolinic acid
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02572141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02572141.